Inmedix selected as a 2022 FiReStarter Company by Future in Review
Immuno-autonomics gains a spotlight NORMANDY PARK, WA, USA, March 2, 2022 /EINPresswire.com/ -- Inmedix, developers of immuno-autonomics and cloud-based clinical diagnostics quantifying stress biology, was honored by its selection as a 2022 FiReStarter …